drugset / Trial / NCT00759330

Flurbiprofen Tape for Treatment of Chronic Low Back Pain

NCT00759330

Phase 2 Completed 127 enrolled Teikoku Pharma USA, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this trial is to evaluate the analgesic efficacy and safety of flurbiprofen tape for chronic low back pain (lasting greater than 3 months).

Timeline

Start
2007-10
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Flurbiprofen Small molecule 63 mg Topical

Indications